These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7716154)

  • 1. Ligand-induced domain motion in the activation mechanism of a G-protein-coupled receptor.
    Luo X; Zhang D; Weinstein H
    Protein Eng; 1994 Dec; 7(12):1441-8. PubMed ID: 7716154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5.
    Shapiro DA; Kristiansen K; Kroeze WK; Roth BL
    Mol Pharmacol; 2000 Nov; 58(5):877-86. PubMed ID: 11040033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics of 5-HT1A and 5-HT2A serotonin receptors with methylated buspirone analogues.
    Bronowska A; Chilmonczyk Z; Leś A; Edvardsen O; Ostensen R; Sylte I
    J Comput Aided Mol Des; 2001 Nov; 15(11):1005-23. PubMed ID: 11989622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand induced conformational states of the 5-HT(1A) receptor.
    Sylte I; Bronowska A; Dahl SG
    Eur J Pharmacol; 2001 Mar; 416(1-2):33-41. PubMed ID: 11282110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6.
    Shapiro DA; Kristiansen K; Weiner DM; Kroeze WK; Roth BL
    J Biol Chem; 2002 Mar; 277(13):11441-9. PubMed ID: 11801601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the binding site pocket of the serotonin 5-Hydroxytryptamine2A receptor. Ser3.36(159) provides a second interaction site for the protonated amine of serotonin but not of lysergic acid diethylamide or bufotenin.
    Almaula N; Ebersole BJ; Zhang D; Weinstein H; Sealfon SC
    J Biol Chem; 1996 Jun; 271(25):14672-5. PubMed ID: 8663249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modelling of human 5-hydroxytryptamine receptor (5-HT2A) and virtual screening studies towards the identification of agonist and antagonist molecules.
    Gandhimathi A; Sowdhamini R
    J Biomol Struct Dyn; 2016 May; 34(5):952-70. PubMed ID: 26327576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studies.
    Dukat M; Mosier PD; Kolanos R; Roth BL; Glennon RA
    J Med Chem; 2008 Feb; 51(3):603-11. PubMed ID: 18201064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of partial agonism: orientation of indoleamine ligands in the binding pocket of the human serotonin 5-HT2A receptor determines relative efficacy.
    Ebersole BJ; Visiers I; Weinstein H; Sealfon SC
    Mol Pharmacol; 2003 Jan; 63(1):36-43. PubMed ID: 12488534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors.
    Roth BL; Shoham M; Choudhary MS; Khan N
    Mol Pharmacol; 1997 Aug; 52(2):259-66. PubMed ID: 9271348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical models of interactions between buspirone analogues and 5-HT1A and 5-HT2A serotonin receptor subtypes.
    Bronowska A; Sylte I; Edvardsen Ø; Østensen R; Leś A; Chilmonczyk Z
    Acta Pol Pharm; 2000 Nov; 57 Suppl():40-5. PubMed ID: 11293260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacophore-directed homology modeling and molecular dynamics simulation of G protein-coupled receptor: study of possible binding modes of 5-HT2C receptor agonists.
    Zuo Z; Chen G; Luo X; Puah C; Zhu W; Chen K; Jiang H
    Acta Biochim Biophys Sin (Shanghai); 2007 Jun; 39(6):413-22. PubMed ID: 17558446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.
    Johnson MP; Loncharich RJ; Baez M; Nelson DL
    Mol Pharmacol; 1994 Feb; 45(2):277-86. PubMed ID: 8114677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics of the 5-HT1a receptor and ligands.
    Sylte I; Edvardsen O; Dahl SG
    Protein Eng; 1993 Sep; 6(7):691-700. PubMed ID: 8248092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics of buspirone analogues interacting with the 5-HT1A and 5-HT2A serotonin receptors.
    Bronowska A; Leś A; Chilmonczyk Z; Filipek S; Edvardsen O; Ostensen R; Sylte I
    Bioorg Med Chem; 2001 Apr; 9(4):881-95. PubMed ID: 11354671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism.
    Kristiansen K; Kroeze WK; Willins DL; Gelber EI; Savage JE; Glennon RA; Roth BL
    J Pharmacol Exp Ther; 2000 Jun; 293(3):735-46. PubMed ID: 10869371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics of serotonin and ritanserin interacting with the 5-HT2 receptor.
    Edvardsen O; Sylte I; Dahl SG
    Brain Res Mol Brain Res; 1992 Jul; 14(3):166-78. PubMed ID: 1331649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational flexibility of serotonin1A receptor ligands from crystallographic data. Updated model of the receptor pharmacophore.
    Chilmonczyk Z; Szelejewska-Wozniakowska A; Cybulski J; Cybulski M; Koziol AE; Gdaniec M
    Arch Pharm (Weinheim); 1997 May; 330(5):146-60. PubMed ID: 9237427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the 5-HT(7) receptor. Determination of the pharmacophore for 5-HT(7) receptor agonism and CoMFA-based modeling of the agonist binding site.
    Vermeulen ES; Schmidt AW; Sprouse JS; Wikström HV; Grol CJ
    J Med Chem; 2003 Dec; 46(25):5365-74. PubMed ID: 14640545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-dependent conformations and dynamics of the serotonin 5-HT(2A) receptor determine its activation and membrane-driven oligomerization properties.
    Shan J; Khelashvili G; Mondal S; Mehler EL; Weinstein H
    PLoS Comput Biol; 2012; 8(4):e1002473. PubMed ID: 22532793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.